SPRYCEL

Product NDC
0003-0528
11-digit product format
000030528
Labeler code
0003
Product ID
0003-0528_8f0a3afc-dde4-40d1-941d-68efd3f62adc
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
dasatinib
Dosage form
TABLET
Route
ORAL
Labeler
E.R. Squibb & Sons, L.L.C.
Application
NDA021986
Marketing category
NDA
Marketing start
2006-06-27
Substance
DASATINIB
Active strength
50 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
SPRYCEL
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DASATINIB50 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiRBZ1571X5H
Rxcui643105, 643107, 643109, 643173, 643175, 643177, 799047, 799830, 1045402, 1045404, 1045406, 1045408

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b66e60ef-563e-ddb8-43b4-d625943af44bProduct name320251209
820d87d5-5779-4353-ae7e-33904df346a1Product name120241218

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0003-0528-11SPRYCEL60 in 1 BOTTLETABLET6047
0003-0528-11SPRYCEL1 in 1 CARTONTABLET147

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0003-0528-11EA - Each0003-052856b4d809-af1d-48e1-a32f-e89ff6ffca8a12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
dasatinibACTIVE INGREDIENTRBZ1571X5HSPRYCEL (DASATINIB) TABLET [E.R. SQUIBB & SONS, L.L.C.]30
dasatinib anhydrousACTIVE MOIETYX78UG0A0RNSPRYCEL (DASATINIB) TABLET [E.R. SQUIBB & SONS, L.L.C.]30
cellulose, microcrystallineINACTIVE INGREDIENTOP1R32D61USPRYCEL (DASATINIB) TABLET [E.R. SQUIBB & SONS, L.L.C.]30
croscarmellose sodiumINACTIVE INGREDIENTM28OL1HH48SPRYCEL (DASATINIB) TABLET [E.R. SQUIBB & SONS, L.L.C.]30
HYDROXYPROPYL CELLULOSE (TYPE H)INACTIVE INGREDIENTRFW2ET671PSPRYCEL (DASATINIB) TABLET [E.R. SQUIBB & SONS, L.L.C.]30
hypromellosesINACTIVE INGREDIENT3NXW29V3WOSPRYCEL (DASATINIB) TABLET [E.R. SQUIBB & SONS, L.L.C.]30
lactose monohydrateINACTIVE INGREDIENTEWQ57Q8I5XSPRYCEL (DASATINIB) TABLET [E.R. SQUIBB & SONS, L.L.C.]30
magnesium stearateINACTIVE INGREDIENT70097M6I30SPRYCEL (DASATINIB) TABLET [E.R. SQUIBB & SONS, L.L.C.]30
polyethylene glycolsINACTIVE INGREDIENT3WJQ0SDW1ASPRYCEL (DASATINIB) TABLET [E.R. SQUIBB & SONS, L.L.C.]30
titanium dioxideINACTIVE INGREDIENT15FIX9V2JPSPRYCEL (DASATINIB) TABLET [E.R. SQUIBB & SONS, L.L.C.]30

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0003-0528SPRYCEL (DASATINIB) TABLET [E.R. SQUIBB & SONS, L.L.C.]47Current NDC, Legacy NDC, 2 package rows20240815_4764f37b-c9e6-4ede-bcc2-8a03b7c521df.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
799047dasatinib 100 MG Oral TabletPSN4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
1045402dasatinib 140 MG Oral TabletPSN4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
643105dasatinib 20 MG Oral TabletPSN4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
643107dasatinib 50 MG Oral TabletPSN4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
643109dasatinib 70 MG Oral TabletPSN4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
1045406dasatinib 80 MG Oral TabletPSN4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
799830SPRYCEL 100 MG Oral TabletPSN4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
1045404SPRYCEL 140 MG Oral TabletPSN4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
643173SPRYCEL 20 MG Oral TabletPSN4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
643175SPRYCEL 50 MG Oral TabletPSN4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
643177SPRYCEL 70 MG Oral TabletPSN4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
1045408SPRYCEL 80 MG Oral TabletPSN4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
799830dasatinib 100 MG Oral Tablet [Sprycel]SBD4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
1045404dasatinib 140 MG Oral Tablet [Sprycel]SBD4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
643173dasatinib 20 MG Oral Tablet [Sprycel]SBD4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
643175dasatinib 50 MG Oral Tablet [Sprycel]SBD4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
643177dasatinib 70 MG Oral Tablet [Sprycel]SBD4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
1045408dasatinib 80 MG Oral Tablet [Sprycel]SBD4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
799047dasatinib 100 MG Oral TabletSCD4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
1045402dasatinib 140 MG Oral TabletSCD4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
643105dasatinib 20 MG Oral TabletSCD4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
643107dasatinib 50 MG Oral TabletSCD4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
643109dasatinib 70 MG Oral TabletSCD4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
1045406dasatinib 80 MG Oral TabletSCD4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
799830Sprycel 100 MG Oral TabletSY4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
1045404Sprycel 140 MG Oral TabletSY4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
643173Sprycel 20 MG Oral TabletSY4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
643175Sprycel 50 MG Oral TabletSY4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
643177Sprycel 70 MG Oral TabletSY4764f37b-c9e6-4ede-bcc2-8a03b7c521df47
1045408Sprycel 80 MG Oral TabletSY4764f37b-c9e6-4ede-bcc2-8a03b7c521df47

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0003-0528-11000030528111 BOTTLE in 1 CARTON (0003-0528-11) / 60 TABLET in 1 BOTTLE1 bottle2006-06-270000-00-00NoNoCurrent